Not applicableUnknownNCT04424095What this trial is testingVenous Disease in Pediatric PopulationWho this might be right forChronic Venous InsufficiencyPediatric ALL University of Catanzaro 100
Not applicableUnknownNCT05068089What this trial is testingHealth, Economic Analysis and Clinical Aspects of Patients With Neurological Disabilities in Enteral Nutrition With Dedicated Formula. The Role of Nissen's Fundoplication in the Management of Gastroesophageal RefluxWho this might be right forGastro-Esophageal RefluxFundoplication Bambino Gesù Hospital and Research Institute 360
Post-approval studies (Phase 4)Study completedNCT04248335What this trial is testingEffect of Obesity on Proton Pump InhibitorsWho this might be right forPediatric ObesityNAFLDGERD Children's Mercy Hospital Kansas City 76
Early research (Phase 1)WithdrawnNCT02442752What this trial is testingPhase 1 Dexlansoprazole Delayed-Release Capsules for Acid-Related Disorders in Infants Aged 1 to 11 MonthsWho this might be right forPediatric Gastroesophageal Reflux Disease Takeda
Not applicableNot Yet RecruitingNCT07036627What this trial is testingIntestinal Microbiota After PPI TreatmentWho this might be right forProton Pump InhibitorsHuman Gastrointestinal TractGastroesophageal Reflux Disease University of Bari 100
Early research (Phase 1)Study completedNCT00687245What this trial is testingPharmacokinetic Study of Esomeprazole Magnesium in Patients 1 to 11 Years-Old With Endoscopically-Proven Gastroesophageal Reflux Disease (GERD)Who this might be right forEndoscopically-Proven GERDReflux AstraZeneca 40
Large-scale testing (Phase 3)WithdrawnNCT00771706What this trial is testingLongitudinal Study of Children With a Chronic Cough and the Impact of Gastroesophageal RefluxWho this might be right forCoughGastroesophageal Reflux Massachusetts Eye and Ear Infirmary
Post-approval studies (Phase 4)Study completedNCT00228527What this trial is testingEsomeprazole for Treatment of GERD in Pediatric PatientsWho this might be right forGastroesophageal Reflux Disease (GERD)Erosive EsophagitisNon-erosive Esophagitis AstraZeneca 100
Testing effectiveness (Phase 2)Study completedNCT02616302What this trial is testingCheck the Safety of Dexlansoprazole and Learn if it Can Treat Symptomatic Nonerosive Gastroesophageal Reflux Disease in Children 2 to 11 Years OldWho this might be right forGastroesophageal Reflux Disease (GERD) Takeda 71
Large-scale testing (Phase 3)Study completedNCT00992589What this trial is testingSafety and Efficacy of Rabeprazole in Infants With Gastroesophageal Erosive Reflux Disease (GERD)Who this might be right forGastroesophageal Reflux Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 344
Post-approval studies (Phase 4)Ended earlyNCT02401035What this trial is testingPREA, PK And Safety PASS Study Of IV Pantoprazole In Pediatric SubjectsWho this might be right forGastroesophageal Reflux Disease Pfizer 19
Early research (Phase 1)Study completedNCT01101646What this trial is testingA Pharmacokinetic and Relative Bioavailability Study With Rabeprazole Sodium in Healthy Adult VolunteersWho this might be right forGastroesophageal Reflux Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 36